546 related articles for article (PubMed ID: 28741159)
1. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
[TBL] [Abstract][Full Text] [Related]
2. Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin.
Jakobiec FA; Mendoza PR
Am J Ophthalmol; 2014 Jan; 157(1):186-208.e2. PubMed ID: 24112633
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas.
Jakobiec FA; Werdich X
Am J Ophthalmol; 2014 Mar; 157(3):687-96.e1-2. PubMed ID: 24333189
[TBL] [Abstract][Full Text] [Related]
4. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.
Mittal R; Araujo I; Czanner G; Coupland SE
Acta Ophthalmol; 2016 Aug; 94(5):e325-30. PubMed ID: 26843360
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features of considerable reduction in androgen receptor expression in sebaceous gland carcinoma of the eyelid.
Yunoki T; Miyakoshi A; Otsuka M; Hayashi A
Int Ophthalmol; 2019 Aug; 39(8):1703-1708. PubMed ID: 30027448
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical staining for adipophilin, perilipin and TIP47.
Muthusamy K; Halbert G; Roberts F
J Clin Pathol; 2006 Nov; 59(11):1166-70. PubMed ID: 16556662
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor γ in eyelid sebaceous gland carcinoma.
Jayaraj P; Sen S; Bhattacharya T; Arora J; Yadav S; Chhoker V; Kumar A; Dhanaraj PS; Yadavilli KS; Verma M
Histopathology; 2016 Aug; 69(2):268-75. PubMed ID: 26791964
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of adipophilin immunostain in periocular carcinomas.
Milman T; Schear MJ; Eagle RC
Ophthalmology; 2014 Apr; 121(4):964-71. PubMed ID: 24290802
[TBL] [Abstract][Full Text] [Related]
9. CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid.
Yunoki T; Hirano T; Tabuchi Y; Furusawa Y; Torigoe M; Nakajima T; Imura J; Hayashi A
Int Ophthalmol; 2020 Feb; 40(2):343-350. PubMed ID: 31571090
[TBL] [Abstract][Full Text] [Related]
10. Ocular sebaceous gland carcinoma: an update of the literature.
Cicinelli MV; Kaliki S
Int Ophthalmol; 2019 May; 39(5):1187-1197. PubMed ID: 29696467
[TBL] [Abstract][Full Text] [Related]
11. HPV-associated Vulvar Intraepithelial Carcinoma With Sebaceous Differentiation: Report of 2 Cases.
Hamza MA; Quick CM; Williams HR; Patil NM; Shalin SC
Int J Gynecol Pathol; 2023 Jul; 42(4):338-346. PubMed ID: 36383010
[TBL] [Abstract][Full Text] [Related]
12. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
[TBL] [Abstract][Full Text] [Related]
13. Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor).
Mulay K; White VA; Shah SJ; Honavar SG
Can J Ophthalmol; 2014 Aug; 49(4):326-32. PubMed ID: 25103648
[TBL] [Abstract][Full Text] [Related]
14. ZEB2/SIP1 as novel prognostic indicator in eyelid sebaceous gland carcinoma.
Bhardwaj M; Sen S; Sharma A; Kashyap S; Chosdol K; Pushker N; Bajaj MS; Bakhshi S
Hum Pathol; 2015 Oct; 46(10):1437-42. PubMed ID: 26220160
[TBL] [Abstract][Full Text] [Related]
15. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.
Plaza JA; Mackinnon A; Carrillo L; Prieto VG; Sangueza M; Suster S
Am J Dermatopathol; 2015 Nov; 37(11):809-21. PubMed ID: 26485238
[TBL] [Abstract][Full Text] [Related]
16. Sebaceous carcinoma: an immunohistochemical reappraisal.
Ansai S; Takeichi H; Arase S; Kawana S; Kimura T
Am J Dermatopathol; 2011 Aug; 33(6):579-87. PubMed ID: 21778832
[TBL] [Abstract][Full Text] [Related]
17. Expression of retinoic acid-binding proteins and retinoic acid receptors in sebaceous cell carcinoma of the eyelids.
Tsai YJ; Wu SY; Huang HY; Ma DH; Wang NK; Hsiao CH; Cheng CY; Yeh LK
BMC Ophthalmol; 2015 Oct; 15():142. PubMed ID: 26503156
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of PD-L1 and PD-1 expression in aggressive eyelid sebaceous gland carcinoma and its clinical significance.
Jayaraj P; Sen S
Indian J Ophthalmol; 2019 Dec; 67(12):1983-1987. PubMed ID: 31755433
[TBL] [Abstract][Full Text] [Related]
19. Topical mitomycin-C for pagetoid invasion of the conjunctiva by eyelid sebaceous gland carcinoma.
Shields CL; Naseripour M; Shields JA; Eagle RC
Ophthalmology; 2002 Nov; 109(11):2129-33. PubMed ID: 12414427
[TBL] [Abstract][Full Text] [Related]
20. Adipophilin expression in sebaceous tumors and other cutaneous lesions with clear cell histology: an immunohistochemical study of 117 cases.
Ostler DA; Prieto VG; Reed JA; Deavers MT; Lazar AJ; Ivan D
Mod Pathol; 2010 Apr; 23(4):567-73. PubMed ID: 20118912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
